The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology

Authors

  • Wilfried Mullens Ziekenhuis Oost Limburg, Genk, Belgium University of Hasselt, Hasselt, Belgium
  • Frank Ruschitzka UniversitätsSpital Zürich, Zürich, Switzerland
  • Petar M. Seferovic University of Belgrade, Faculty of Medicine, Belgrade, Serbia
  • Gerasimos Filippatos National and Kapodistrian University of Athens, Athens, Greece University of Cyprus, Nicosia, Cyprus
  • Marco Metra University of Brescia, Brescia, Italy
  • Patrick Rossignol Université de Lorraine, Inserm, Centre d’Investigations Clinique 1433 and Inserm U1116; CHRU Nancy; F-CRIN INI-CRCT, Nancy, France
  • Francesco Orso University of Florence, Florence, Italy
  • W.H. Wilson Tang Cleveland Clinic, Cleveland, OH, USA
  • Jeffrey M. Testani Yale University, New Haven, CT, USA
  • Pieter Martens Ziekenhuis Oost Limburg, Genk, Belgium University of Hasselt, Hasselt, Belgium
  • Hans-Peter Brunner-La Rocca Maastricht University Medical Center, Maastricht, The Netherlands
  • Alexandre Mebazaa University of Paris Diderot, Hôpitaux Universitaires Saint Louis Lariboisière, APHP, U 942 Inserm, F-CRIN INI-CRCT, Paris, France
  • Veli-Pekka Harjola Emergency Medicine, University of Helsinki, Helsinki University Hospital, Helsinki, Finland
  • Kevin Damman University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Andrew J. Coats IRCCS, San Raffaele Pisana, Rome, Italy

DOI:

https://doi.org/10.22141/2307-1257.8.1.2019.157796

Keywords:

diuretics, heart failure, acute heart failure, pharmacotherapy, loop diuretics

Abstract

The vast majority of acute heart failure episodes are characterized by increasing symptoms and signs of congestion with volume overload. The goal of therapy in those patients is the relief of congestion through achieving a state of euvolaemia, mainly through the use of diuretic therapy. The appropriate use of diuretics however remains challenging, especially when worsening renal function, diuretic resistance and electrolyte disturbances occur. This position paper focuses on the use of diuretics in heart failure with congestion. The manuscript addresses frequently encountered challenges, such as (i) evaluation of congestion and clinical euvolaemia, (ii) assessment of diuretic response/resistance in the treatment of acute heart failure, (iii) an approach towards stepped pharmacologic diuretic strategies, based upon diuretic response, and (iv) management of common electrolyte disturbances. Recommendations are made in line with available guidelines, evidence and expert opinion.

Downloads

Download data is not yet available.

Published

2021-09-08

How to Cite

Mullens, W., Ruschitzka, F., M. Seferovic, P., Filippatos, G., Metra, M., Rossignol, P., Orso, F., Wilson Tang, W., M. Testani, J., Martens, P., Brunner-La Rocca, H.-P., Mebazaa, A., Harjola, V.-P., Damman, K., & J. Coats, A. (2021). The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology. KIDNEYS, 8(1), 43–61. https://doi.org/10.22141/2307-1257.8.1.2019.157796

Issue

Section

Guidelines